Ascendis Pharma A/S (ASND)
USD 135.7
(-3.28%)
USD 135.7
(-3.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 825.58 Million EUR | -24.24% |
| 2022 | 1.08 Billion EUR | 0.44% |
| 2021 | 1.08 Billion EUR | 10.73% |
| 2020 | 979.79 Million EUR | 44.78% |
| 2019 | 676.73 Million EUR | 112.16% |
| 2018 | 318.96 Million EUR | 51.18% |
| 2017 | 210.97 Million EUR | 11.0% |
| 2016 | 190.07 Million EUR | 44.24% |
| 2015 | 131.77 Million EUR | 124.6% |
| 2014 | 58.67 Million EUR | 119.74% |
| 2013 | 26.7 Million EUR | 5.1% |
| 2012 | 25.4 Million EUR | 11.34% |
| 2011 | 22.81 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 758.74 Million EUR | -5.51% |
| 2024 Q1 | 802.5 Million EUR | -2.8% |
| 2023 Q3 | 873.21 Million EUR | 6.0% |
| 2023 Q4 | 825.58 Million EUR | -5.45% |
| 2023 FY | 825.58 Million EUR | -24.24% |
| 2023 Q1 | 966.27 Million EUR | -11.33% |
| 2023 Q2 | 823.82 Million EUR | -14.74% |
| 2022 FY | 1.08 Billion EUR | 0.44% |
| 2022 Q4 | 1.08 Billion EUR | -14.42% |
| 2022 Q3 | 1.27 Billion EUR | -4.03% |
| 2022 Q2 | 1.32 Billion EUR | -3.66% |
| 2022 Q1 | 1.37 Billion EUR | 26.94% |
| 2021 FY | 1.08 Billion EUR | 10.73% |
| 2021 Q2 | 851.84 Million EUR | -11.75% |
| 2021 Q3 | 1.2 Billion EUR | 41.48% |
| 2021 Q4 | 1.08 Billion EUR | -9.98% |
| 2021 Q1 | 965.31 Million EUR | -1.48% |
| 2020 Q3 | 1.04 Billion EUR | 86.61% |
| 2020 Q4 | 979.79 Million EUR | -6.34% |
| 2020 FY | 979.79 Million EUR | 44.78% |
| 2020 Q1 | 621.4 Million EUR | -8.18% |
| 2020 Q2 | 560.6 Million EUR | -9.78% |
| 2019 Q3 | 734.95 Million EUR | -4.2% |
| 2019 FY | 676.73 Million EUR | 112.16% |
| 2019 Q4 | 676.73 Million EUR | -7.92% |
| 2019 Q2 | 767.15 Million EUR | 0.68% |
| 2019 Q1 | 761.93 Million EUR | 138.88% |
| 2018 FY | 318.96 Million EUR | 51.18% |
| 2018 Q4 | 318.96 Million EUR | -4.85% |
| 2018 Q2 | 368.86 Million EUR | 1.11% |
| 2018 Q1 | 364.82 Million EUR | 72.92% |
| 2018 Q3 | 335.23 Million EUR | -9.12% |
| 2017 Q1 | 172.76 Million EUR | -9.11% |
| 2017 Q4 | 210.97 Million EUR | -4.98% |
| 2017 Q2 | 142.4 Million EUR | -17.57% |
| 2017 FY | 210.97 Million EUR | 11.0% |
| 2017 Q3 | 222.04 Million EUR | 55.92% |
| 2016 Q2 | 102.73 Million EUR | -8.83% |
| 2016 Q3 | 86.75 Million EUR | -15.56% |
| 2016 Q1 | 112.67 Million EUR | -14.49% |
| 2016 FY | 190.07 Million EUR | 44.24% |
| 2016 Q4 | 190.07 Million EUR | 119.1% |
| 2015 Q1 | 161.28 Million EUR | 174.9% |
| 2015 Q4 | 131.77 Million EUR | -6.72% |
| 2015 Q3 | 141.26 Million EUR | -4.62% |
| 2015 Q2 | 148.11 Million EUR | -8.17% |
| 2015 FY | 131.77 Million EUR | 124.6% |
| 2014 Q2 | 20.12 Million EUR | 0.0% |
| 2014 Q3 | 15.72 Million EUR | -21.83% |
| 2014 Q4 | 58.67 Million EUR | 273.04% |
| 2014 FY | 58.67 Million EUR | 119.74% |
| 2014 Q1 | - EUR | -100.0% |
| 2013 Q1 | - EUR | 0.0% |
| 2013 Q4 | 26.7 Million EUR | 0.0% |
| 2013 FY | 26.7 Million EUR | 5.1% |
| 2012 FY | 25.4 Million EUR | 11.34% |
| 2011 FY | 22.81 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -10609.221% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -24.874% |
| IO Biotech, Inc. | 150.71 Million USD | -447.769% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -745.152% |
| Organovo Holdings, Inc. | 6.34 Million USD | -12903.418% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -4521.96% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -26670.128% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -434.509% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -523.447% |
| Savara Inc. | 177.56 Million USD | -364.952% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -547.936% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -45.776% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -2820.117% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -3633.275% |
| Soligenix, Inc. | 9.79 Million USD | -8326.656% |
| Aptose Biosciences Inc. | 12.92 Million USD | -6288.734% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -2274.219% |
| Century Therapeutics, Inc. | 360.69 Million USD | -128.89% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -1580.345% |
| Precision BioSciences, Inc. | 159.78 Million USD | -416.699% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -40.35% |
| Kura Oncology, Inc. | 448.93 Million USD | -83.899% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -7684.719% |
| Dyadic International, Inc. | 8.21 Million USD | -9944.571% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -203.358% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -27.147% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -302.429% |
| Autolus Therapeutics plc | 375.38 Million USD | -119.933% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -2501.093% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -132.439% |
| GRI Bio, Inc. | 2.95 Million USD | -27829.195% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -384.173% |
| IGM Biosciences, Inc. | 423.41 Million USD | -94.985% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -271.04% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -883.53% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -11894.241% |
| Opthea Limited | 188.79 Million USD | -337.302% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -460.64% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -398.832% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -61.199% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | 0.898% |
| Surrozen, Inc. | 46.08 Million USD | -1691.638% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -19061.286% |
| Cingulate Inc. | 3.49 Million USD | -23546.059% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -473.218% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -74.602% |
| Acelyrin, Inc. | 742.69 Million USD | -11.162% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -127.454% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -4462.667% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -92.264% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -390.912% |
| ADMA Biologics, Inc. | 329.18 Million USD | -150.8% |
| PureTech Health plc | 693.97 Million USD | -18.965% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -2147.78% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -6884.071% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -284.878% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -43.391% |
| Synaptogenix, Inc. | 31.11 Million USD | -2553.455% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -6675.993% |
| ChromaDex Corporation | 54.96 Million USD | -1402.05% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -5591.095% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -11139.879% |
| Exelixis, Inc. | 2.94 Billion USD | 71.941% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -241.571% |
| Better Therapeutics, Inc. | 22.94 Million USD | -3498.427% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -126.474% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -4.673% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -399.387% |
| Seer, Inc. | 436.26 Million USD | -89.238% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -5518.149% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -711.707% |
| Gritstone bio, Inc. | 177.76 Million USD | -364.416% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -765.577% |
| Avid Bioservices, Inc. | 336.55 Million USD | -145.304% |
| Insmed Incorporated | 1.32 Billion USD | 37.918% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -6895.314% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -3832.678% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -63.09% |
| MediWound Ltd. | 66.45 Million USD | -1142.25% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -1020.169% |
| Fortress Biotech, Inc. | 167.52 Million USD | -392.811% |
| OmniAb, Inc. | 401.98 Million USD | -105.378% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -130.225% |
| Zai Lab Limited | 1.03 Billion USD | 20.333% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -72.553% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -210.11% |
| Veracyte, Inc. | 1.13 Billion USD | 27.441% |
| Abeona Therapeutics Inc. | 64 Million USD | -1189.939% |
| FibroGen, Inc. | 423.52 Million USD | -94.93% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -105.675% |
| ContextLogic Inc. | 423 Million USD | -95.174% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -4673.559% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -17329.931% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -411.716% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 92.754% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -75.959% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -9276.343% |
| ImmuCell Corporation | 43.8 Million USD | -1784.553% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 81.052% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -250.711% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -765.577% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -188.752% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | 44.629% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -116.123% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -126.286% |
| Vaxxinity, Inc. | 44.35 Million USD | -1761.401% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -59.7% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -4336.414% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -7604.828% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -4720.273% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -996.863% |
| Senti Biosciences, Inc. | 119.48 Million USD | -590.96% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -6446.189% |
| Apollomics, Inc. | 55.38 Million USD | -1390.579% |
| 89bio, Inc. | 596.26 Million USD | -38.459% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -7.842% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -15869.724% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -376.312% |
| Ardelyx, Inc. | 297.57 Million USD | -177.435% |
| Pluri Inc. | 39.52 Million USD | -1988.666% |
| Prothena Corporation plc | 696.38 Million USD | -18.554% |
| Pulmatrix, Inc. | 33.95 Million USD | -2331.2% |
| Celularity Inc. | 143.88 Million USD | -473.767% |
| MeiraGTx Holdings plc | 458.16 Million USD | -80.193% |
| Omeros Corporation | 378.26 Million USD | -118.254% |
| Ainos, Inc. | 31.84 Million USD | -2492.777% |
| Humacyte, Inc. | 128.22 Million USD | -543.868% |
| Mesoblast Limited | 669.15 Million USD | -23.378% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -2541.118% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -1104.709% |
| Blueprint Medicines Corporation | 1.04 Billion USD | 21.316% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -225.483% |
| Summit Therapeutics Inc. | 202.94 Million USD | -306.795% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -9891.371% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -165.432% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | 36.541% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -534.145% |
| Cytokinetics, Incorporated | 824.31 Million USD | -0.154% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -3808.474% |
| Nutriband Inc. | 7.51 Million USD | -10882.707% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -945.656% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 88.569% |
| Evogene Ltd. | 51.1 Million USD | -1515.599% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -1405.639% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -8571.879% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -51.101% |
| BioLineRx Ltd. | 63.92 Million USD | -1191.493% |
| Atai Life Sciences N.V. | 293.47 Million USD | -181.311% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -567.664% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -50.638% |
| MediciNova, Inc. | 66.26 Million USD | -1145.793% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -838.722% |
| MiMedx Group, Inc. | 239.04 Million USD | -245.366% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 56.621% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -70.19% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -34.706% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -3061.127% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -11186.22% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -142.898% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -400.107% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -56.86% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -197.302% |
| Allakos Inc. | 243.61 Million USD | -238.897% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -220.375% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -32.834% |
| BioAtla, Inc. | 119.65 Million USD | -589.956% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -28.429% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -760.569% |
| Precigen, Inc. | 151.04 Million USD | -446.591% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -13959.099% |
| XOMA Corporation | 234.3 Million USD | -252.362% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -273.172% |
| Incyte Corporation | 6.78 Billion USD | 87.827% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -556.04% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -436.433% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4262.72% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 62.971% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -42.276% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -647.347% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -5346.702% |
| UroGen Pharma Ltd. | 178.31 Million USD | -363.004% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -75.382% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -148463.022% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -1409.465% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -261.557% |
| Chimerix, Inc. | 212.77 Million USD | -288.011% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -2455.918% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -10506.517% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -78.592% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -3544.948% |
| Portage Biotech Inc. | 7.77 Million USD | -10513.022% |
| OncoCyte Corporation | 74.89 Million USD | -1002.37% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -40504.343% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -9590.841% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -14167.115% |
| Purple Biotech Ltd. | 44.3 Million USD | -1763.543% |
| NextCure, Inc. | 129.41 Million USD | -537.923% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -4475.167% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -10247.473% |
| Generation Bio Co. | 374.75 Million USD | -120.299% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -66.384% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -142.251% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -8070.084% |
| NLS Pharmaceutics AG | 1.84 Million USD | -44607.499% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -228.088% |
| Novavax, Inc. | 1.85 Billion USD | 55.502% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -19719.918% |
| Curis, Inc. | 77.28 Million USD | -968.279% |
| Daré Bioscience, Inc. | 21.28 Million USD | -3779.234% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -10110.079% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -8474.547% |
| Bicycle Therapeutics plc | 595.34 Million USD | -38.674% |
| BeiGene, Ltd. | 5.8 Billion USD | 85.779% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -6684.345% |
| Alector, Inc. | 621.82 Million USD | -32.768% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -130.642% |
| Erasca, Inc. | 395.29 Million USD | -108.852% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -15251.19% |
| Aura Biosciences, Inc. | 255.07 Million USD | -223.664% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -1356.267% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -3627.065% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -18995.918% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -2034.403% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 87.933% |
| Histogen Inc. | 19.07 Million USD | -4228.564% |
| Fortress Biotech, Inc. | 167.52 Million USD | -392.811% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -31.347% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -10.074% |
| Galecto, Inc. | 38.22 Million USD | -2059.696% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -6883.018% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -99.493% |
| Molecular Templates, Inc. | 35.38 Million USD | -2233.287% |
| PDS Biotechnology Corporation | 59.39 Million USD | -1290.109% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -59.548% |
| Amarin Corporation plc | 831.68 Million USD | 0.733% |
| TG Therapeutics, Inc. | 329.58 Million USD | -150.491% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -3223.352% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -77.307% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -163.398% |
| Onconetix, Inc. | 88.82 Million USD | -829.491% |
| MacroGenics, Inc. | 306.82 Million USD | -169.079% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -545.651% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -1430.338% |
| Adagene Inc. | 115.72 Million USD | -613.381% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -168.141% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -170.64% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -135.022% |
| SciSparc Ltd. | 11.18 Million USD | -7283.178% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6660.12% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -1350.928% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -224.184% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -420.655% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -141.849% |
| Relay Therapeutics, Inc. | 843.98 Million USD | 2.179% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 78.444% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -72821.471% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -3942.24% |
| 2seventy bio, Inc. | 565.42 Million USD | -46.012% |
| Clene Inc. | 52.34 Million USD | -1477.324% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -535.585% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8793.327% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -15105.642% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -471.732% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -210366.649% |
| Absci Corporation | 234.48 Million USD | -252.093% |
| XBiotech Inc. | 227.24 Million USD | -263.306% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -240.374% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -478.953% |
| Entera Bio Ltd. | 11.76 Million USD | -6917.314% |
| Trevena, Inc. | 40.6 Million USD | -1933.215% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -192.123% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -87.222% |
| INmune Bio, Inc. | 57 Million USD | -1348.373% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -696.813% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -265.535% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -4864.742% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -1156.793% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -6965.583% |
| Jaguar Health, Inc. | 50.76 Million USD | -1526.356% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -2326.912% |
| NexImmune, Inc. | 8.59 Million USD | -9506.608% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -555.79% |
| Clearmind Medicine Inc. | 4.32 Million USD | -18991.414% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -10128.942% |
| Kronos Bio, Inc. | 213.27 Million USD | -287.092% |
| Innoviva, Inc. | 1.24 Billion USD | 33.608% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -31.128% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 97.504% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -416.689% |
| Verastem, Inc. | 149.71 Million USD | -451.428% |
| ProKidney Corp. | 420.55 Million USD | -96.31% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9544.021% |
| Imunon, Inc. | 21.91 Million USD | -3666.696% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -124.046% |
| Statera Biopharma, Inc. | 21.16 Million USD | -3799.855% |
| ImmunityBio, Inc. | 504.45 Million USD | -63.66% |
| Korro Bio, Inc. | 221.66 Million USD | -272.451% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -4.649% |
| Kineta, Inc. | 10.28 Million USD | -7930.221% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -74.947% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -1305.629% |
| GT Biopharma, Inc. | 14.1 Million USD | -5751.492% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -123.117% |
| Celularity Inc. | 143.88 Million USD | -473.767% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -29.941% |
| CalciMedica, Inc. | 12.18 Million USD | -6675.437% |
| Cibus, Inc. | 544.41 Million USD | -51.648% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -119.308% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -383.059% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -555.779% |
| Kodiak Sciences Inc. | 479.37 Million USD | -72.223% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -46.044% |
| Annexon, Inc. | 297.67 Million USD | -177.346% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -377.19% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -500.562% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -2941.284% |
| Moderna, Inc. | 18.42 Billion USD | 95.519% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -486.113% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 72.389% |
| Vor Biopharma Inc. | 209.82 Million USD | -293.459% |
| Eyenovia, Inc. | 28.77 Million USD | -2768.676% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -1424.348% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -258.129% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -171.794% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -200.269% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -11328.391% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -10.232% |
| Immunocore Holdings plc | 597 Million USD | -38.289% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -105.081% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -2827.613% |
| Alkermes plc | 2.13 Billion USD | 61.353% |
| Arcellx, Inc. | 825.13 Million USD | -0.055% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -406.093% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -46.895% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -753.593% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -2584.836% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -18401.109% |
| Moolec Science SA | 24.05 Million USD | -3332.61% |
| Biomea Fusion, Inc. | 199.92 Million USD | -312.944% |
| RenovoRx, Inc. | 1.46 Million USD | -56215.621% |
| Geron Corporation | 394.07 Million USD | -109.499% |
| Mereo BioPharma Group plc | 66.49 Million USD | -1141.503% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -911.786% |
| Royalty Pharma plc | 16.38 Billion USD | 94.96% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -38.762% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -11702.843% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -2779.017% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -6764.266% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -265.207% |
| Humacyte, Inc. | 128.22 Million USD | -543.868% |
| Structure Therapeutics Inc. | 482.01 Million USD | -71.278% |
| NLS Pharmaceutics AG | 1.84 Million USD | -44607.499% |
| Genelux Corporation | 27.89 Million USD | -2859.836% |
| ESSA Pharma Inc. | 149.12 Million USD | -453.631% |
| aTyr Pharma, Inc. | 122.06 Million USD | -576.339% |
| Notable Labs, Ltd. | 19.54 Million USD | -4124.896% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -130616.068% |
| Mustang Bio, Inc. | 17.74 Million USD | -4553.292% |
| Immunovant, Inc. | 666.71 Million USD | -23.83% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4745.753% |
| Vericel Corporation | 353.65 Million USD | -133.443% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | 52.368% |
| Akari Therapeutics, Plc | 4.35 Million USD | -18857.222% |
| Acasti Pharma Inc. | 73.3 Million USD | -1026.312% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -18035.677% |
| Vaxcyte, Inc. | 1.4 Billion USD | 41.361% |
| Orgenesis Inc. | 14.55 Million USD | -5573.358% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -694.246% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -3524.016% |
| GH Research PLC | 226.3 Million USD | -264.82% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -1499.882% |
| PepGen Inc. | 143.05 Million USD | -477.124% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -2060.261% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -746.304% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -13959.099% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -19061.286% |
| Silo Pharma, Inc. | 7.74 Million USD | -10558.043% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -17194.242% |
| Belite Bio, Inc | 94.64 Million USD | -772.326% |
| Pharming Group N.V. | 462.85 Million USD | -78.369% |
| XOMA Corporation | 234.3 Million USD | -252.362% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -668.445% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4262.72% |
| Bionomics Limited | 27.64 Million USD | -2885.946% |
| Xencor, Inc. | 952.69 Million USD | 13.342% |
| Replimune Group, Inc. | 487.72 Million USD | -69.274% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -375.224% |
| Cassava Sciences, Inc. | 151.66 Million USD | -444.356% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -27.319% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -18435.069% |
| Turnstone Biologics Corp. | 112.81 Million USD | -631.806% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -2447.636% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8793.327% |
| MEI Pharma, Inc. | 41.37 Million USD | -1895.376% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -198.105% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -18401.109% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -25539.348% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -2141.555% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -2319.232% |
| scPharmaceuticals Inc. | 94.47 Million USD | -773.831% |
| HilleVax, Inc. | 344.43 Million USD | -139.694% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -370.297% |
| Tharimmune, Inc. | 10.94 Million USD | -7442.092% |
| Genprex, Inc. | 10.67 Million USD | -7637.031% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -23400.911% |
| Immunic, Inc. | 54.29 Million USD | -1420.446% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -757.735% |
| Aptorum Group Limited | 20.64 Million USD | -3899.919% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -356.905% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -23400.911% |
| OKYO Pharma Limited | 1.54 Million USD | -53465.58% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -1191.012% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -4161.974% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -644.367% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -6.133% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -12434.489% |
| bluebird bio, Inc. | 619.16 Million USD | -33.34% |
| DBV Technologies S.A. | 182.98 Million USD | -351.175% |
| Compugen Ltd. | 121.33 Million USD | -580.425% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -18995.918% |
| Peak Bio, Inc. | 2.59 Million USD | -31697.19% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -4431.959% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -7025.729% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -1010.048% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -767.104% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -379.082% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -497.105% |
| Benitec Biopharma Inc. | 52.21 Million USD | -1481.281% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -141.499% |
| Adicet Bio, Inc. | 207.29 Million USD | -298.267% |
| Prime Medicine, Inc. | 193.85 Million USD | -325.887% |
| Aditxt, Inc. | 44.57 Million USD | -1751.992% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -28.888% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -18435.069% |
| Quantum-Si incorporated | 298.25 Million USD | -176.81% |
| GlycoMimetics, Inc. | 45.31 Million USD | -1721.825% |
| PolyPid Ltd. | 15.37 Million USD | -5270.719% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -592.107% |
| Invivyd, Inc. | 229.18 Million USD | -260.234% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -6684.178% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -604.276% |
| CorMedix Inc. | 82.05 Million USD | -906.078% |
| Instil Bio, Inc. | 325.63 Million USD | -153.535% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -26.295% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -533.187% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -1062.848% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -352.649% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -668.789% |
| AbCellera Biologics Inc. | 1.48 Billion USD | 44.521% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -227.536% |
| Surrozen, Inc. | 46.08 Million USD | -1691.638% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -117.027% |
| Verona Pharma plc | 308.12 Million USD | -167.94% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -207.462% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 57.88% |
| Evaxion Biotech A/S | 12.88 Million USD | -6305.551% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -9.685% |
| Shattuck Labs, Inc. | 159.56 Million USD | -417.402% |
| AlloVir, Inc. | 190.79 Million USD | -332.707% |
| BioVie Inc. | 25.2 Million USD | -3175.054% |
| Codexis, Inc. | 136.56 Million USD | -504.555% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -12793.753% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -26670.128% |
| Agenus Inc. | 313.91 Million USD | -162.999% |
| Virax Biolabs Group Limited | 5.48 Million USD | -14954.553% |
| Lantern Pharma Inc. | 43.64 Million USD | -1791.482% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -68.341% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -3918.628% |
| Immix Biopharma, Inc. | 19.92 Million USD | -4043.44% |
| Celcuity Inc. | 191.21 Million USD | -331.749% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -911.29% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -166.211% |
| IN8bio, Inc. | 33.7 Million USD | -2349.159% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -44526.324% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -823.444% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -259.844% |
| Liquidia Corporation | 120.43 Million USD | -585.527% |
| Quantum-Si incorporated | 298.25 Million USD | -176.81% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -3061.127% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | 14.429% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -1723.011% |
| United Therapeutics Corporation | 7.16 Billion USD | 88.481% |
| Solid Biosciences Inc. | 164.93 Million USD | -400.541% |
| Immuneering Corporation | 102.58 Million USD | -704.787% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -668.789% |
| uniQure N.V. | 831.68 Million USD | 0.734% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -1255.065% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -13395.541% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -201.436% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -1528.473% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -227.416% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -15807.515% |
| Cue Biopharma, Inc. | 61.53 Million USD | -1241.763% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -4203.294% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -254.044% |
| Zura Bio Limited | 100.84 Million USD | -718.685% |
| Forte Biosciences, Inc. | 38.98 Million USD | -2017.976% |
| Elevation Oncology, Inc. | 89.09 Million USD | -826.678% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -11328.391% |
| Immunome, Inc. | 148.54 Million USD | -455.801% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -426.271% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -849.398% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -377.371% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -338.079% |
| Altimmune, Inc. | 210.64 Million USD | -291.942% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -997.476% |
| Rallybio Corporation | 115.62 Million USD | -614.052% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -7149.622% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -360.181% |
| Moolec Science SA | 24.05 Million USD | -3332.61% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -20169.185% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -33930.791% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -292.585% |
| NeurAxis, Inc. | 509.49 Thousand USD | -161939.301% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | 44.496% |
| Lumos Pharma, Inc. | 40.63 Million USD | -1931.564% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -849.398% |
| 180 Life Sciences Corp. | 5.25 Million USD | -15597.134% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -2274.219% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -1072.246% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9544.021% |
| Nutriband Inc. | 7.51 Million USD | -10882.707% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -314.241% |
| argenx SE | 4.54 Billion USD | 81.825% |
| Neurogene Inc. | 222.57 Million USD | -270.929% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -27.677% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -13211.625% |
| CervoMed Inc. | 9.97 Million USD | -8178.619% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -82.234% |
| Sesen Bio, Inc. | 189.17 Million USD | -336.417% |
| AnaptysBio, Inc. | 452.38 Million USD | -82.495% |
| Design Therapeutics, Inc. | 289.64 Million USD | -185.036% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -1033.659% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -15137.855% |
| Achilles Therapeutics plc | 161.45 Million USD | -411.339% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -25894.553% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -224.159% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -983.277% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -1325.49% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -56.795% |
| Palisade Bio, Inc. | 14.05 Million USD | -5775.228% |
| Beam Therapeutics Inc. | 1.45 Billion USD | 43.442% |
| AEON Biopharma, Inc. | 6.84 Million USD | -11961.169% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -203.673% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -5920.966% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -5.797% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -209.216% |
| Athira Pharma, Inc. | 160.24 Million USD | -415.203% |
| Vaccinex, Inc. | 3.63 Million USD | -22637.18% |
| HCW Biologics Inc. | 28.51 Million USD | -2795.409% |
| XOMA Corporation | 234.3 Million USD | -252.362% |
| Nektar Therapeutics | 398.03 Million USD | -107.417% |
| Arvinas, Inc. | 1.3 Billion USD | 36.717% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4745.753% |
| Merus N.V. | 458.49 Million USD | -80.065% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -303.975% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -358.14% |
| Rezolute, Inc. | 132.73 Million USD | -521.972% |
| Clene Inc. | 52.34 Million USD | -1477.324% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -5431.987% |
| BeyondSpring Inc. | 24.8 Million USD | -3227.906% |
| Synlogic, Inc. | 75.55 Million USD | -992.769% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -6859.931% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -8716.606% |
| Peak Bio, Inc. | 2.59 Million USD | -31697.19% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -372.215% |
| Krystal Biotech, Inc. | 818.35 Million USD | -0.884% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -243.368% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -13.75% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -22979.308% |
| MannKind Corporation | 475.19 Million USD | -73.735% |
| Ikena Oncology, Inc. | 192.09 Million USD | -329.787% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -6073.075% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -608.421% |
| Gossamer Bio, Inc. | 311.91 Million USD | -164.682% |
| CohBar, Inc. | 16.36 Million USD | -4944.628% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -2247.886% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -11186.22% |
| Legend Biotech Corporation | 1.84 Billion USD | 55.34% |
| Mural Oncology plc | 301.74 Million USD | -173.604% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -2544.841% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -14433.946% |
| Disc Medicine, Inc. | 367.99 Million USD | -124.347% |
| Champions Oncology, Inc. | 26.13 Million USD | -3059.295% |
| REGENXBIO Inc. | 573.97 Million USD | -43.838% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -30386.008% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -434.755% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -6736.831% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -142.795% |
| Vaxart, Inc. | 91.83 Million USD | -799.038% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -1278.186% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -456.6% |
| Cellectis S.A. | 334.27 Million USD | -146.982% |
| Longeveron Inc. | 12.17 Million USD | -6679.332% |
| Repare Therapeutics Inc. | 253.9 Million USD | -225.161% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 74.711% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -311.053% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 60.472% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -50705.354% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -197.283% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -406.191% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -495.043% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -3134.805% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 96.368% |
| Denali Therapeutics Inc. | 1.15 Billion USD | 28.454% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6660.12% |
| Veru Inc. | 50.59 Million USD | -1531.726% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -1712.366% |
| Cingulate Inc. | 3.49 Million USD | -23546.059% |
| Passage Bio, Inc. | 150.54 Million USD | -448.399% |
| Context Therapeutics Inc. | 16.06 Million USD | -5039.766% |
| Exicure, Inc. | 11.58 Million USD | -7029.421% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -119.543% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -410.75% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 60.472% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -4625.2% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -148.114% |
| Nuvalent, Inc. | 732.38 Million USD | -12.726% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -5424.509% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -821.887% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -5717.68% |
| OmniAb, Inc. | 401.98 Million USD | -105.378% |
| Anew Medical, Inc. | 19.45 Million USD | -4143.364% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -2989.014% |
| Lipocine Inc. | 23 Million USD | -3489.341% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -490.519% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -170.184% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -883.53% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -579.272% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -10304.373% |
| Sage Therapeutics, Inc. | 882.27 Million USD | 6.425% |
| Ocugen, Inc. | 64.54 Million USD | -1179.048% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -562.904% |
| Q32 Bio Inc. | 306.11 Million USD | -169.695% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -19519.463% |
| Alumis Inc. Common Stock | 89.61 Million USD | -821.291% |
| Equillium, Inc. | 50.53 Million USD | -1533.855% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -997.928% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -1900.282% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -48439.586% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -3058.207% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -1181.152% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -22050.844% |
| Dominari Holdings Inc. | 57.55 Million USD | -1334.357% |
| Edesa Biotech, Inc. | 8.89 Million USD | -9186.236% |
| vTv Therapeutics Inc. | 11.01 Million USD | -7393.075% |
| Bio-Techne Corporation | 2.81 Billion USD | 70.653% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | 11.901% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -1.742% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -197.332% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -1879.73% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -23.667% |
| Nkarta, Inc. | 378.88 Million USD | -117.899% |
| BioCardia, Inc. | 2.98 Million USD | -27539.337% |
| Iterum Therapeutics plc | 26.25 Million USD | -3044.015% |